Cellcolabs raised €6.2M in a funding round in Mar 2022. The company is based in Solna, Sweden. Investors in the round: Fredrik Jung-Abbou, Ash Pournouri, Filip Engelbert and 7 others. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.